You are here: Industry Insights > Parkinson

News List

Important Finding by Chinese Scientists: Vitamin B12 is Expected to Treat PD PharmaSources/Yefenghong
May 06, 2019
Parkinson’s disease (PD) is the second most common neurodegenerative disease after Alzheimer's disease, which affects about 1% population in the world. PD patients may continue to increase as society develops and the aging of the population becomes increa
Niclosamide could lead the fight against Parkinson’s disease europeanpharmaceuticalreview
May 05, 2019
Drug molecule in tapeworm medicine activates protein implicated in the development of Parkinson’s disease…
Anti-TNFα therapy may help reduce risk of developing Parkinson’s disease europeanpharmaceuticalreview
April 25, 2019
Mount Sinai shows the potential link between Parkinson’s disease and inflammatory bowel disease, suggests anti-TNFα therapy may reduce the risk of developing Parkinson’s…
Parkinson's Disease: Servier and Oncodesign Join Forces to Investigate New Line of Research firstwordpharma
March 13, 2019
Servier and Oncodesign (ALONC – FR0011766229) (Paris:ALONC) have announced a strategic partnership for the research and development of potential drug candidates for Parkinson's disease.
Ireland to lead €7 M Parkinson’s research project biospectrumasia
March 13, 2019
A new research study aims to deepen the understanding of Parkinson’s so that better treatments can be developed in the future. The project, which will be coordinated by RCSI, has been awarded €7 million by the Innovative Medicines Initiative (IMI) with ph
Direct infusion of GDNF into brain offers hope for Parkinson’s pharmaceutical-technology
February 28, 2019
An experimental study funded by Parkinson’s UK has demonstrated promising results for infusion of a naturally-occurring protein called GDNF directly into the brain...
Axovant Announces Feedback From FDA Meeting Regarding AXO-Lenti-PD for Parkinson’s Disease and Progress in Ongoing SUNRISE-PD Phase 2 Clinical Trial firstwordpharma
December 06, 2018
Axovant Sciences (NASDAQ: AXON), a clinical-stage company developing innovative gene therapies for neurological conditions, today announced feedback from a face-to-face pre-IND meeting with the U.S. Food and Drug Administration (FDA) regarding AXO-Lenti-P
UCB’s new app uses voice AI to help Parkinson’s patients fiercepharma
December 05, 2018
April would like to talk—to Parkinson’s patients and caregivers. "She" is the virtual health assistant on UCB’s new mobile app built specifically for Parkinson’s disease.
After seeing POC data, Kyowa advances Parkinson’s program despite being dropped by Lundbeck fiercebiotech
August 21, 2018
Kyowa Hakko Kirin has posted (PDF) a look at proof-of-concept data on adenosine A2A receptor antagonist KW-6356 in early Parkinson’s disease patients. The data emboldened Kyowa to commit to a larger phase 2 trial, despite its one-time partner Lundbeck wal
Alan Alda Reveals Parkinson's Diagnosis drugs
August 01, 2018
Alan Alda revealed Tuesday that he's been living with Parkinson's disease for more than three years.

Previous page 1 2 3 4 5 6 7 8 9 Next page